Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18529410 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL11449382 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL20479049 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL454167 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL18529411 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL18529409 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL454166 | 1.00 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL10995198 | 0.94 | ALDH1A1 (0.45) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL580300 | 0.83 | ALDH1A1 (0.38) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL580302 | 0.83 | ALDH1A1 (0.38) | ALDH1A1CYP3A4ALOX15TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026047126-A1 | ISOMERIZATION OF 2,6,6-TRIMETHYLCYCLOHEX-1 OR 2-ENYL KETONES OR ESTERS CATALYZED BY STRONG BASE | FIRMENICH SA (CH) | 2026-03-05 | — | — | WO | claimed |
| EP-3919044-B1 | COMPOSITION AND METHOD FOR IMPROVING FRAGRANCE INTENSITY WITH ISOPROPYL MYRISTATE | INT FLAVORS & FRAGRANCES INC (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-114982899-A | Cold water aquatic product polypeptide powder fishy smell removing essence, preparation method and application | 通又通(武汉)生命科学有限公司 | 2022-09-02 | — | — | CN | claimed |
| EP-4022017-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF RAW MATERIAL MALODOURS IN SOAP BASES | Firmenich SA (CH) | 2022-07-06 | — | — | EP | claimed |
| US-11002716-B2 | Method of resolving defined known or suspected allergens in a complex mixture of perfume ingredients, and compositions | GIVAUDAN SA (CH) | 2021-05-11 | — | — | US | claimed |
| US-10792384-B2 | Rolled fibrous structures comprising encapsulated malodor reduction compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-10-06 | — | — | US | claimed |
| EP-3465198-B1 | METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS | GIVAUDAN SA (CH) | 2020-08-19 | — | — | EP | claimed |
| US-20190184049-A1 | Rolled Fibrous Structures Comprising Encapsulated Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-06-20 | — | — | US | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089462-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089465-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090558-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089318-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | ALDH1A1 252/4885CYP3A4 134/4885ALOX15 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.